{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T05:55:04Z","timestamp":1778997304891,"version":"3.51.4"},"reference-count":60,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The aim of this study was to examine how the status of the oral cavity, composition and properties of saliva change in oncological patients with and without Medication-Related Osteonecrosis of the Jaw (MRONJ) undergoing bisphosphonate therapy. Materials and Methods: A retrospective case\u2013control study of 49 oncological patients using bisphosphonates (BPs) was conducted. The study population was divided into two groups\u2014Group I consisted of 29 patients with MRONJ and Group II of 20 patients without MRONJ. The control group consisted of 32 persons without oncological history and without antiresorptive therapy. Standard dental examination included the assessment of the number of teeth remaining, teeth with caries and fillings, Approximal Plaque Index (API) and Bleeding on Probing (BOP). In terms of MRONJ, localization and stage were assessed. Laboratory tests of saliva included determination of pH and concentrations of Ca and PO4 ions, total protein, lactoferrin, lysozyme, sIgA, IgA, cortisol, neopterin, activity of amylase at rest, and stimulated saliva. The buffering capacity and microbiological tests (Streptococcus mutans, Lactobacillus spp. load) of stimulated saliva were also determined. Results: There were no statistically significant differences between the selected oral parameters and saliva of Group I and Group II. Significant differences were found between Group I and the control group. BOP, lysozyme and cortisol concentration were higher, while the number of teeth with fillings, Ca and neopterin concentrations were lower in comparison to the control group. In Group I, a significantly higher percentage of patients with a high colony count (&gt;105) of Streptococcus mutans and Lactobacillus spp. was also found. The significant differences between Group II and the control group concerned the concentrations of lysozyme, Ca ions, sIgA, neopterin and the colony count of Lactobacillus spp. In the Group I patients who received a significantly higher cumulative dose of BP compared to the Group II, a significant positive correlation was found between the received BP dose and the BOP. Most MRONJ foci were stage 2 and were mainly located in the mandible. Conclusions: Among oncological patients with and without MRONJ undergoing BP therapy compared to the control group, there are statistically significant differences in the dental, periodontal and microbiological status and in the composition of the saliva. Particularly noteworthy are the statistically significant differences in the decreased level of Ca ions, the increased level of cortisol and the elements of saliva related to the immune response (lysozyme, sIgA, neopterin). Additionally, a higher cumulative dose of BPs may affect the susceptibility to the development of osteonecrosis of the jaws. Patients undergoing antiresorptive therapy should receive multidisciplinary medical care, including dental care.<\/jats:p>","DOI":"10.3390\/medicina59061073","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:50:31Z","timestamp":1685695831000},"page":"1073","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Study of Oral Health Parameters and the Properties and Composition of Saliva in Oncological Patients with and without Medication-Related Osteonecrosis of the Jaw Who Take Bisphosphonates"],"prefix":"10.3390","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1472-2533","authenticated-orcid":false,"given":"Hanna","family":"Sobczak-Jaskow","sequence":"first","affiliation":[{"name":"Department of Maxillofacial Surgery, Medical University of Gdansk, 80-210 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5479-0704","authenticated-orcid":false,"given":"Barbara","family":"Kocha\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Conservative Dentistry, Medical University of Gdansk, 80-210 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Drogoszewska","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Medical University of Gdansk, 80-210 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: Mechanism of Action and Role in Clinical Practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1023\/A:1008626026484","article-title":"Bisphosphonates in bone diseases","volume":"20","author":"Sparidans","year":"1998","journal-title":"Pharm. World Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bone.2011.02.003","article-title":"Bisphosphonates in oncology","volume":"49","author":"Coleman","year":"2011","journal-title":"Bone"},{"key":"ref_6","first-page":"268","article-title":"Bisphosphonates for the treatment of patients with cancer","volume":"13","author":"Krakowska","year":"2017","journal-title":"Oncol. Clin. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Otto, S., Aljohani, S., Fliefel, R., Ecke, S., Ristow, O., Burian, E., Troeltzsch, M., Pautke, C., and Ehrenfeld, M. (2021). Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ). Medicina, 57.","DOI":"10.3390\/medicina57050463"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.critrevonc.2005.03.011","article-title":"Management of bone metastases in cancer: A review","volume":"56","author":"Selvaggi","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw\u2014A 4-year prospective study","volume":"126","author":"Hallmer","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jcms.2015.04.018","article-title":"Bisphosphonates enhance bacterial adhesion and biofilm formation on bone hydroxyapatite","volume":"43","author":"Kos","year":"2015","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5114\/aoms.2014.40738","article-title":"Association of dental and periodontal status with bisphosphonate-related osteonecrosis of the jaws. A retrospective case controlled study","volume":"10","author":"Kos","year":"2014","journal-title":"Arch. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tripleo.2008.07.011","article-title":"Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: A pilot study","volume":"106","author":"Carmagnola","year":"2008","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of Microbial Biofilms in Osteonecrosis of the Jaws Secondary to Bisphosphonate Therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of Life Implications of Bisphosphonate-Associated Osteonecrosis of the Jaw","volume":"16","author":"Miksad","year":"2011","journal-title":"Oncologist"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws\u2014characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000439347","article-title":"Bisphosphonate-Mediated Oral Ulcers: A Rare Differential Diagnosis of Erosive Oral Lesions","volume":"232","author":"Lengfeld","year":"2016","journal-title":"Dermatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jcms.2017.12.015","article-title":"Cytotoxic and inflammatory effects of alendronate and zolendronate on human osteoblasts, gingival fibroblasts and osteosarcoma cells","volume":"46","author":"Arndt","year":"2018","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.bbrc.2003.09.083","article-title":"A novel non-containing-nitrogen bisphosphonate inhibits both in vitro and in vivo angiogenesis","volume":"310","author":"Ledoux","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tripleo.2011.02.028","article-title":"Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue","volume":"112","author":"Wehrhan","year":"2011","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1100\/tsw.2010.38","article-title":"Saliva: Physiology and diagnostic potential in health and disease","volume":"10","author":"Farnaud","year":"2010","journal-title":"Sci. World J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jdent.2018.08.010","article-title":"The role of natural salivary defences in maintaining a healthy oral microbiota","volume":"80","year":"2019","journal-title":"J. Dent."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev-food-030212-182700","article-title":"The secretion, components, and properties of saliva","volume":"4","author":"Carpenter","year":"2013","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcms.2020.01.005","article-title":"Saliva diagnostics in patients suffering from bisphosphonate-associated osteonecrosis of the jaw: Results of an observational study","volume":"48","author":"Stockmann","year":"2020","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cydejko, A., Kusiak, A., Grzybowska, M.E., Kocha\u0144ska, B., Ochoci\u0144ska, J., Maj, A., and \u015awietlik, D. (2020). Selected Physicochemical Properties of Saliva in Menopausal Women-A Pilot Study. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17072604"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.joms.2015.03.034","article-title":"Salivary Biomarkers Associated With Bone Deterioration in Patients With Medication-Related Osteonecrosis of the Jaws","volume":"73","author":"Kolokythas","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Lorenzo-Pouso, A.I., Bravo, S.B., Carballo, J., Chantada-V\u00e1zquez, M.D.P., Bag\u00e1n, J., Bag\u00e1n, L., Chamorro-Petronacci, C.M., Conde-Amboage, M., L\u00f3pez-L\u00f3pez, R., and Garc\u00eda-Garc\u00eda, A. (2022). Quantitative proteomics in medication-related osteonecrosis of the jaw: A proof-of-concept study. Oral Dis.","DOI":"10.1111\/odi.14201"},{"key":"ref_30","first-page":"46","article-title":"Salivary proteomics in bisphosphonate-related osteonecrosis of the jaw","volume":"1","author":"Michalowicz","year":"2015","journal-title":"Oral Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/odi.12150","article-title":"Interleukin-6 concentration changes in plasma and saliva in bisphosphonate-related osteonecrosis of the jaws","volume":"20","author":"Bagan","year":"2014","journal-title":"Oral Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijom.2012.12.011","article-title":"The effect of bisphosphonate yherpay on neutrophil function: A potential biomarker","volume":"4","author":"Favot","year":"2013","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sobczak-Jaskow, H., Kocha\u0144ska, B., and Drogoszewska, B. (2023). Composition and properties of Saliva in Patients with Osteoporosis Taking Antiresorptive Drugs. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20054294"},{"key":"ref_34","first-page":"521","article-title":"New aspects of diagnosis and therapy of periodontal diseases for dental practitioners","volume":"37","author":"Lange","year":"1986","journal-title":"Quintessenz"},{"key":"ref_35","unstructured":"Knychalska-Karwan, Z. (2010). Zbi\u00f3r Wska\u017anik\u00f3w Stomatologicznych, Klasyfikacji i Test\u00f3w, CZELEJ. [2nd ed.]."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.4317\/jced.60039","article-title":"Correlations between different plaque indexes and bleeding on probing: A concurrent validity study","volume":"15","author":"Carvalho","year":"2023","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1749-6632.1993.tb18343.x","article-title":"Methods for collecting saliva","volume":"694","author":"Navazesh","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"ref_39","first-page":"77","article-title":"Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa","volume":"19","author":"Rahnama","year":"2015","journal-title":"Contemp. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00520-015-2720-y","article-title":"Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients","volume":"23","author":"Mercadante","year":"2015","journal-title":"Support Care Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10096-014-2160-5","article-title":"Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): The missing link?","volume":"33","author":"Tacconelli","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect Dis."},{"key":"ref_42","first-page":"85","article-title":"Effects of an oral hygiene regimen on progression of gingivitis\/early periodontitis: A randomized controlled trial","volume":"55","author":"Zini","year":"2021","journal-title":"Can. J. Dent. Hyg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.17691\/stm2022.14.2.07","article-title":"Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves","volume":"14","author":"Timchenko","year":"2022","journal-title":"Sovrem Tekhnologii Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1902\/jop.2010.100355","article-title":"Study of orthophosphate, pyrophosphate, and pyrophosphatase in saliva with reference to calculus formation and inhibition","volume":"82","author":"Pradeep","year":"2011","journal-title":"J. Periodontol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00520-009-0710-7","article-title":"A novel bioassay model to determine clinically significant bisphosphonate levels","volume":"17","author":"Scheper","year":"2009","journal-title":"Support Care Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.7150\/ijms.60013","article-title":"Efficacy of bisphosphonates in detection of early enamel caries using NIR fluorescence imaging and inhibition of caries progression","volume":"18","author":"Sun","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.17096\/jiufd.16663","article-title":"Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats","volume":"51","author":"Tuncer","year":"2017","journal-title":"J. Istanb. Univ. Fac. Dent."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4103\/0972-124X.118316","article-title":"Association of salivary calcium, phosphate, pH and flow rate on oral health: A study on 90 subjects","volume":"17","author":"Fiyaz","year":"2013","journal-title":"J. Indian Soc. Periodontol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"606043","DOI":"10.3389\/fimmu.2021.606043","article-title":"The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8701423","DOI":"10.1155\/2016\/8701423","article-title":"Salivary Secretory Immunoglobulin (SIgA) and Lysozyme in Malignant Tumor Patients","volume":"2016","author":"Sun","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5604\/01.3001.0010.3851","article-title":"Neopterin as a marker of cellular immunological response","volume":"71","author":"Michalak","year":"2017","journal-title":"Postep. Hig. Med. Dosw."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr. Drug Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2009.05.008","article-title":"Neopterin, a prognostic marker in human malignancies","volume":"287","author":"Sucher","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4103\/0970-9290.152207","article-title":"Estimation of salivary neopterin in chronic periodontitis","volume":"25","author":"Mahendra","year":"2014","journal-title":"Indian J. Dent. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0009-8981(97)00154-X","article-title":"Periodontitis and Concentrations of the Cellular Immune Activation Marker Neopterin in Saliva and Urine","volume":"268","author":"Vrecko","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"ref_56","first-page":"191","article-title":"Salivary secretory immunoglobulin A reactivity: A comparison to cortisol and \u03b1-amylase patterns in the same breast cancer survivors","volume":"22","author":"Lambert","year":"2018","journal-title":"Contemp. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Lopez-Jornet, P., Zavattaro, E., Mozaffari, H.R., Ramezani, M., and Sadeghi, M. (2019). Evaluation of the salivary level of cortisol in patients with oral lichen planus: A meta-analysis. Medicina, 55.","DOI":"10.3390\/medicina55050213"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bbi.2009.07.007","article-title":"Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer","volume":"23","author":"Sephton","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"ref_59","first-page":"10","article-title":"Association between salivary cortisol level and caries in early childhood","volume":"19","author":"Caruso","year":"2018","journal-title":"Eur. J. Paediatr. Dent."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Dubar, M., Clerc-Urm\u00e8s, I., Baumann, C., Cl\u00e9ment, C., Alauzet, C., and Bisson, C. (2020). Relations of psychosocial factors and cortisol with periodontal and bacterial parameters: A prospective clinical study in 30 patients with periodontitis before and after non-surgical treatment. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17207651"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/6\/1073\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:47:45Z","timestamp":1760125665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/6\/1073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["medicina59061073"],"URL":"https:\/\/doi.org\/10.3390\/medicina59061073","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]}}}